Overview

Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
To assess whether vitamin D supplementation after surgery of a first cutaneous malignant melanoma protects against relapse of the disease.
Phase:
Phase 3
Details
Lead Sponsor:
Universitaire Ziekenhuizen Leuven
Collaborators:
Katholieke Universiteit Leuven
KU Leuven
Treatments:
Cholecalciferol
Ergocalciferols
Vitamin D
Vitamins